Category: uncategorised

For this discussion, I want to get the groups understanding and opinions on psychopathy. Let’s elaborate on a psychopath’s emotional experiences, personality characteristics, and tests that assess the traits. How common are psychopaths? What do we know about this concept of ‘successful psychopath?’

What is the groups opinion on Lifestyle Theory (Hindelang, Gottfredson, and Farofalo, 1978)? Please comment on possible strengths and limitations to this theory.

This assignment consists of two parts:

Part 1 is the interview itself. Preferably, write the interview in a narrative form instead of transcribing the questions and answers. For instance:

_____ described the psychiatrist as very professional, but not warm or interested in personal details about the experienced challenges at work and relationships. Per _______s report, the side effects were not intense, but the desired effects took a long time to emerge.

Make sure you write the generic names of medications in lowercase and the brand names in capital initial letters. For instance, fluoxetine (Prozac), venlafaxine (Effexor), risperidone (Risperdal), alprazolam (Xanax), etc.

Part 2 is your reflection as a prospective therapist working with clients who use psychotropic medications. Elaborate on your countertransference and biases, cultural and identity diversity sensitivity, clinical judgment, possible interventions you would employ as a therapist, and areas for your further growth.

Parts 1 and 2 are equally important. It will be helpful to imagine that you should strive to obtain 50 points in Part 1 and 50 points in Part 2.

Structure of the Interview Paper

Part 1: Interview (2 to 3 double-spaced pages)

• Firstly, keep the interviewees name confidential by changing it when writing the paper. Begin the interview section by providing demographic information (sexual orientation, gender identity, ethnic background, age, cultural background) and a brief list of the medications to treat the interviewees symptoms. For instance:

The interviewee Tina Doe is a 35-year-old transgender woman of Haitian descent, who was reportedly diagnosed with anxiety after the deportation of her parents and an aunt nearly two months ago. Tina states that for a miracle she managed to go to the hospital, and was prescribed fluoxetine and alprazolam with no recollection of their dosages and the names of the prescribing physicians

If you have a history of use of psychotropic medications and feel that this assignment will be significantly helpful in your development as a prospective therapist, you can be the interviewee.

• Start the interview this way:

State your name and identify yourself with your credentials (e.g., clinical psychology master’s students, MFT trainee, etc), and provide the name of the course and explain the purpose of this interview, and thank them for the opportunity to interview him/her/them. Emphasize that all information shared will be kept strictly confidential and that a fictitious name will substitute for the real name. Make the interviewee feel as safe and comfortable as possible. And present yourself with no judgment, respectfully and warmly. Make sure to make note of this (stating your credentials and the purpose of this interview) in your paper; it can be a brief sentence or two but this and the closing protocol do need to be explicitly mentioned, with the intent of training you to get used to information that must be included in intake or psychopharmocological interviews with clients (and documenting that it was verbalized).

• Questions to ask the interviewee:

1. Have you ever undergone treatment with psychotropic medications? If yes (for the purposes of this paper, of course the answer does need to be yes), what was the reason you started taking psychotropic medications? Do you know the names of these medications, the dosages, and who prescribed them?
2. How would you evaluate the quality of the interaction with the prescribing doctor/nurse regarding warmth, listening, attention, and professionalism? How long was the assessment interview, and how long did it take to select the medications? Did your doctor/nurse explain what the medications were for and their potential side effects?
3. How did you respond to the prescribed medications? Did you have positive effects?
4. Did you have side effects? How did you address them?
5. Were you being treated in psychotherapy conjointly?
6. (If not) Would you have considered including psychotherapy if circumstances were favorable? In what ways could psychotherapy and the therapist be beneficial?
7. (If yes) How do you evaluate the treatment with psychotherapy with prescribed psychotropic medications? Was this combination effective? Why? Was your therapist able to support you if you experienced undesirable effects from medications?
8. Is there anything you would like to add to this interview?

• Before ending the interview:

Ask him/her/them if they would like you to email a draft of the interview for their review.

Thank the interviewee sincerely for the opportunity to learn from his/her/their history. Make brief note of this important step in your paper.

Part 2: Insights and reflection as a prospective therapist working with clients who take medications (1 to 3 double-spaced pages)

• Elaborate on your countertransference and how it can impact your relationship with the client as a therapist. Part 2 must display self-awareness derived from deep intellectual reflection and intrapsychic investigation.
• Assumptions you had about the interviewee based on his/her/their appearance, cultural and ethnic background, social class, race, and privilege. How did the assumptions impact the interaction?
• If the interviewee were your therapy client, how would you support him/her/them? What would you do if there were complaints of side effects? Which interventions would you employ in the therapy sessions?
• What are the areas for further growth as a prospective therapist working with clients who use psychotropic medications in their treatment?

Clarity, Structure, and ComplianceFormatting and Presentation

Criterion Score

Narrative Form

2 points

Interview is presented in a narrative form (not Q&A transcription), effectively weaving the responses into a descriptive story.

Score of Narrative Form,

/ 2

Medication Nomenclature

2 points

Correct use of lowercase generic names and capitalized initial Brand names (e.g., fluoxetine (Prozac)).

Score of Medication Nomenclature,

/ 2

Length Compliance

2 points

Paper adheres to the suggested minimum length (Part 1: 2-3 pages; Part 2: 1-3 pages).

Score of Length Compliance,

/ 2

Part 1: Interview Content and StructureIntroduction and Demographics

Criterion Score

Confidentiality and Fictitious Name

2 points

Interviewee is kept confidential using a fictitious name.

Score of Confidentiality and Fictitious Name,

/ 2

Opening Protocol

5 points

Student states name, identifies credentials (e.g., MFT student), names course, explains purpose, and thanks the interviewee. The tone is respectful, warm, and non-judgmental.

Score of Opening Protocol,

/ 5

Demographic Information

10 points

Comprehensive demographic details provided (sexual orientation, gender identity, ethnic/cultural background, age).

Score of Demographic Information,

/ 10

Interview Execution and DetailInterview

Criterion Score

Reason and Medication History (Q1)

5 points

Clear details on the reason for starting medication, names, dosages (if known), and prescribing professional.

Score of Reason and Medication History (Q1),

/ 5

Prescriber Interaction (Q2)

5 points

Thorough evaluation of the quality of interaction (warmth, listening, professionalism), assessment length, and explanation of side effects/purpose.

Score of Prescriber Interaction (Q2),

/ 5

Response and Side Effects (Q3 & Q4)

5 points

Detailed account of positive/desired effects, side effects experienced, and how they were addressed.

Score of Response and Side Effects (Q3 & Q4),

/ 5

Psychotherapy Conjointly (Q5)

5 points

Comprehensive exploration of whether psychotherapy was combined with medication, evaluation of the combined treatment, and therapist support for side effects. (Or) Thorough discussion of considering psychotherapy and its potential benefits (if not combined).

Score of Psychotherapy Conjointly (Q5),

/ 5

Closing Protocol (Q6 & Ending)

2 points

Interviewee’s optional additions are noted, the offer to email a draft is made, and an effusive thank you is included.

Score of Closing Protocol (Q6 & Ending),

/ 2

Narrative Quality and FlowPart 1: Overall

Criterion Score

Engagement and Clarity

5 points

The narrative is engaging, well-organized, and the interviewees experience is conveyed with clarity and depth.

Score of Engagement and Clarity,

/ 5

Part 2: Insights and ReflectionSelf-Awareness and Introspection

Criterion Score

Countertransference and Biases

10 points

In-depth elaboration on potential countertransference specific to this client’s case and its likely impact on the therapeutic relationship.

Score of Countertransference and Biases,

/ 10

Assumptions and Impact

10 points

Deep intellectual reflection on assumptions (based on appearance, culture, race, class, privilege, etc.) and a critical analysis of how these assumptions did or could have impacted the interaction.

Score of Assumptions and Impact,

/ 10

Clinical Application and GrowthCountertransference and Biases

Criterion Score

Client Support and Interventions

15 points

Concrete and specific ways the student would support the client, including addressing side effect complaints, and outlining possible clinical interventions tailored to the case.

Score of Client Support and Interventions,

/ 15

Cultural/Identity Sensitivity

10 points

Reflection on and demonstration of sensitivity toward the client’s cultural background, identity diversity, and clinical judgment regarding medication use (integrated throughout the support/interventions section).

Score of Cultural/Identity Sensitivity,

/ 10

Areas for Further Growth

5 points

Clear identification and elaboration of specific, actionable areas for professional growth related to working with clients on psychotropic medications